WallStreetZen

NASDAQ: AMGN
Amgen Inc Stock Forecast, Predictions & Price Target

Analyst price target for AMGN

Based on 17 analysts offering 12 month price targets for Amgen Inc.
Min Forecast
$200.00-17.08%
Avg Forecast
$253.59+5.14%
Max Forecast
$300.00+24.38%

Should I buy or sell AMGN stock?

Buy
Strong Buy
5 analysts 27.78%
Buy
4 analysts 22.22%
Hold
8 analysts 44.44%
Sell
0 analysts 0%
Strong Sell
1 analysts 5.56%

AMGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Anonymous
Morgan Stanley
Strong BuyMaintains$278.00+15.26%2021-04-28
Matthew Harrison
Morgan Stanley
Strong BuyMaintains$279.00+15.68%2021-03-05
Alethia Young
Cantor Fitzgerald
Strong BuyMaintains$295.00+22.31%2021-02-03
Christopher Raymond
Piper Sandler
Strong BuyMaintains$260.00+7.80%2021-02-03
Michael Yee
Jefferies
Strong BuyMaintains$300.00+24.38%2020-07-29
Jay Olson
Oppenheimer
BuyMaintains$277.00+14.85%2021-06-07
Tiago Fauth
Credit Suisse
BuyMaintains$259.00+7.38%2021-04-28
Evan Seigerman
Credit Suisse
BuyMaintains$265.00+9.87%2021-02-03
Dane Leone
Raymond James
BuyUpgrades$255.00+5.73%2020-10-26
Geoffrey Porges
SVB Leerink
HoldMaintains$238.00-1.32%2021-06-07

1 of 2

Forecast return on equity

Is AMGN forecast to generate an efficient return?
Company
121.04%
Industry
71.23%
Market
61.34%
AMGN's Return on Equity is forecast to be high in 3 years (121.04%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is AMGN forecast to generate an efficient return on assets?
Company
18.06%
Industry
16.07%
Market
18.93%
AMGN is forecast to generate higher Return on Assets (18.06%) than the US Drug Manufacturers - General industry average (16.07%)
Forecast

AMGN earnings per share forecast

What is AMGN's earnings per share in the next 3 years based on estimates from 13 analysts?
Avg 1 year Forecast
$16.35+34.46%
Avg 2 year Forecast
$17.82+46.54%
Avg 3 year Forecast
$19.45+59.98%
AMGN's earnings are forecast to grow at a rate of 16.88% per year, which is not exceptional
Forecast

AMGN revenue forecast

What is AMGN's revenue in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$25.9B+3.01%
Avg 2 year Forecast
$27.1B+7.84%
Avg 3 year Forecast
$28.1B+11.66%
AMGN's revenue is forecast to grow at a rate of 3.74% per year, which is not exceptional
Forecast

AMGN earnings growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
16.88%
Industry
29.85%
Market
19.57%
AMGN's earnings are forecast to grow slower (16.88% per year) than the US Drug Manufacturers - General industry average (29.85%)
Forecast
AMGN's earnings are forecast to grow slower (16.88% per year) than the US market average (19.57%)
Forecast
AMGN's earnings are forecast to grow faster (16.88% per year) than the risk-free savings rate (1.5%)
Forecast

AMGN revenue growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
3.74%
Industry
5.33%
Market
14.55%
AMGN's revenues are forecast to grow slower (3.74% per year) than the US Drug Manufacturers - General industry average (5.33%)
Forecast
AMGN's revenues are forecast to grow slower (3.74% per year) than the US market average (14.55%)
Forecast

Amgen Stock Forecast FAQ

Is Amgen Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 18 Wall Street analysts covering (NASDAQ: AMGN) stock is to Buy AMGN stock.

Out of 18 analysts, 5 (27.78%) are recommending AMGN as a Strong Buy, 4 (22.22%) are recommending AMGN as a Buy, 8 (44.44%) are recommending AMGN as a Hold, 0 (0%) are recommending AMGN as a Sell, and 1 (5.56%) are recommending AMGN as a Strong Sell.

What is AMGN's earnings growth forecast for 2021-2023?

(NASDAQ: AMGN) Amgen's forecast annual earnings growth rate of 16.88% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 29.85%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.57%.

Amgen's earnings in 2021 is $7,085,000,000.On average, 13 Wall Street analysts forecast AMGN's earnings for 2021 to be $9,393,957,671, with the lowest AMGN earnings forecast at $9,112,426,218, and the highest AMGN earnings forecast at $9,767,417,762. On average, 13 Wall Street analysts forecast AMGN's earnings for 2022 to be $10,238,092,387, with the lowest AMGN earnings forecast at $9,422,685,370, and the highest AMGN earnings forecast at $11,462,352,021.

In 2023, AMGN is forecast to generate $11,176,971,056 in earnings, with the lowest earnings forecast at $9,773,163,302 and the highest earnings forecast at $13,731,840,265.

What is AMGN's revenue growth forecast for 2021-2023?

(NASDAQ: AMGN) Amgen's forecast annual revenue growth rate of 3.74% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.55%.

Amgen's revenue in 2021 is $25,164,000,000.On average, 9 Wall Street analysts forecast AMGN's revenue for 2021 to be $14,892,725,445,005, with the lowest AMGN revenue forecast at $14,447,159,977,970, and the highest AMGN revenue forecast at $15,147,541,286,904. On average, 10 Wall Street analysts forecast AMGN's revenue for 2022 to be $15,591,361,258,930, with the lowest AMGN revenue forecast at $14,783,848,613,766, and the highest AMGN revenue forecast at $16,390,301,558,622.

In 2023, AMGN is forecast to generate $16,143,463,398,819 in revenue, with the lowest revenue forecast at $15,371,042,787,458 and the highest revenue forecast at $17,245,714,769,598.

What is AMGN's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: AMGN) forecast ROA is 18.06%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.07%.

What is AMGN's Price Target?

According to 17 Wall Street analysts that have issued a 1 year AMGN price target, the average AMGN price target is $253.59, with the highest AMGN stock price forecast at $300.00 and the lowest AMGN stock price forecast at $200.00.

On average, Wall Street analysts predict that Amgen's share price could stay at $253.59 by Jun 7, 2022. The average Amgen stock price prediction forecasts a potential downside of N/A from the current AMGN share price of $241.19.

What is AMGN's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: AMGN) Amgen's current Earnings Per Share (EPS) is $12.16. On average, analysts forecast that AMGN's EPS will be $16.35 for 2021, with the lowest EPS forecast at $15.86, and the highest EPS forecast at $17.00. On average, analysts forecast that AMGN's EPS will be $17.82 for 2022, with the lowest EPS forecast at $16.40, and the highest EPS forecast at $19.95. In 2023, AMGN's EPS is forecast to hit $19.45 (min: $17.01, max: $23.90).

What is AMGN's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: AMGN) forecast ROE is 121.04%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.